{"id":"W4376273227","doi":"10.1093/oncolo/oyad116","title":"Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; Swedish Orphan Biovitrum; LEO Pharma; Servier; Chinese Academy of Medical Sciences; KU Leuven; Ministry of Education, Culture, Sports, Science and Technology; Bayer HealthCare; Insmed; ARCA Biopharma; Kowa Company; Prothena; Five Prime Therapeutics; Agios Pharmaceuticals; Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Esperion Therapeutics; Alnylam Pharmaceuticals; Cook Medical; Janssen Scientific Affairs; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science; GlaxoSmithKline; University of Ottawa; Yale University; Alexion Pharmaceuticals; Daiichi-Sankyo; McMaster University; Brigham and Women's Hospital; Moderna; Pfizer; Heart and Stroke Foundation of Canada; CSL Behring; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Janssen Pharmaceuticals; Audentes Therapeutics; Amgen; Sanofi; American Heart Association","keywords":"Thrombosis; Intensive care medicine; Cancer; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001645362,0.0001231901,0.0004120228,0.00007957505,0.0001274126,0.000009023962,0.00005491962,0.00006687066,0.00008799518],"category_scores_gemma":[0.0000282963,0.00007259502,0.00005830499,0.0005546876,0.0001166585,0.00003259878,0.0000361631,0.00005444345,0.00001236596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003246263,"about_ca_system_score_gemma":0.00005130888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008216703,"about_ca_topic_score_gemma":0.001057903,"domain_scores_codex":[0.9992504,0.00005974462,0.0001842633,0.000152421,0.0001542673,0.0001989422],"domain_scores_gemma":[0.9994882,0.00007338987,0.0001337789,0.0001994702,0.00005537229,0.00004973706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001696135,0.002294957,0.03339003,0.0001406776,0.0009971225,0.00002012882,0.002870505,0.00009054936,0.001224675,0.001549488,0.04425967,0.9129926],"study_design_scores_gemma":[0.001071326,0.001296698,0.3844769,0.00003804656,0.0004352065,0.000001553023,0.001868277,0.00004061064,0.0005665314,0.0001137961,0.6100204,0.00007070179],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9212734,0.02110267,0.000001811013,0.04507397,0.001182789,0.001131963,0.00005072476,0.0002193578,0.009963353],"genre_scores_gemma":[0.5316625,0.46642,0.00002700359,0.0003323455,0.0003560435,0.00022745,0.0000503091,0.00001612726,0.0009082847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9129219,"threshold_uncertainty_score":0.2960339,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03496671495848225,"score_gpt":0.3464161656841737,"score_spread":0.3114494507256915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}